Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

No studies have compared mirtazapine with duloxetine in patients with major depressive disorder (MDD). Fifty-six patients were nonrandomly assigned to a 4-week treatment with either 15 to 45 mg/day of mirtazapine (n = 22) or 20 to 60 mg/day of duloxetine (n = 34). The primary efficacy measurements w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagao, Kei, Kishi, Taro, Moriwaki, Masatsugu, Fujita, Kiyoshi, Hirano, Shigeki, Yamanouchi, Yoshio, Funahashi, Toshihiko, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678901/
https://www.ncbi.nlm.nih.gov/pubmed/23766648
http://dx.doi.org/10.2147/NDT.S43600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678901/
https://www.ncbi.nlm.nih.gov/pubmed/23766648
http://dx.doi.org/10.2147/NDT.S43600

Ejemplares similares